Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOCARNITINE vs LEVOMEPROMAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOCARNITINE vs LEVOMEPROMAZINE: Safety Overview

Metric LEVOCARNITINE LEVOMEPROMAZINE
Total FAERS Reports 392 3,024
Deaths Reported 91 585
Death Rate 23.2% 19.3%
Hospitalizations 183 1,564
Average Patient Age 40.9 yrs 44.1 yrs
% Female Patients 52.6% 47.2%
FDA Approval Date Apr 10, 1986 Approved Prior to Jan 1, 1982
Manufacturer Saptalis Pharmaceuticals, LLC N/A
Route ORAL N/A
Marketing Status Prescription Discontinued